AI predicts embryo health without invasive testing
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study tests whether an artificial intelligence model can accurately predict if an embryo has the right number of chromosomes using only images, instead of needing a biopsy. If successful, this could allow more patients to avoid the risks and costs of invasive genetic testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 40 years old (if female) or between 20 and 55 (if male).
- You are planning IVF with genetic testing (PGT) for chromosome problems, single-gene disorders, or structural chromosome issues.
- You have at least one Day 5 or Day 6 embryo that is developed enough for a biopsy, with good quality ratings.
- You and your partner agree to join the study and sign a consent form.
- You do not have any medical reason that would make IVF or PGT unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether artificial intelligence can better identify which embryos are most likely to result in a successful pregnancy during fertility treatment. Researchers will use an AI system to analyze embryo images on days 5–7 of development to help doctors choose the best embryo to transfer.
This study tests a new non-invasive way to check how embryos are developing before they are frozen and later transferred. It looks at fluid around the embryo to see if it can give extra information about embryo health.
This study looks at embryo health using a DNA test called PGT-A for couples having IVF. It may help researchers better understand what the test can and cannot tell about which embryos are healthiest.
This study tests whether adding a non-invasive genetic test (called NiPGT-A) on the fluid around the embryo can improve success rates for women under 35 who have good-quality embryos. It focuses on the first or second IVF cycle with a single frozen embryo transfer.
This trial tests an artificial intelligence tool that automatically ranks embryos to help doctors choose the best one for transfer. It is for people doing an IVF or ICSI cycle with a "freeze-all" strategy, meaning all embryos are frozen for later use.
This trial uses artificial intelligence to assess the quality of eggs and embryos during IVF. It aims to help doctors select the best embryos for transfer, potentially increasing the chance of a successful pregnancy.
Hear when a new The Focus is to Validate the Accuracy of a Non-invasive Artificial Intelligence Model for the Prediction of the Human Blastocyst Ploidy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.